Kaitlyn Landi

Kaitlyn Landi supports the National Institute on Drug Abuse (NIDA) in advancing scientific research through strategic procurement of specialized scientific and technical services. While her formal title is not publicly listed, her procurement activities are central to enabling NIDA’s mission of translating neurobiological and behavioral research into clinical and public health applications. She manages a diverse portfolio of acquisitions focused on analytical instrumentation, laboratory testing, and biomedical research support, ensuring that grantees and research partners have access to cutting-edge capabilities. Her work directly facilitates the procurement of equipment and services critical to substance use disorder studies, including high-throughput screening, neuroimaging support, and data analysis infrastructure. Landi maintains consistent contracting relationships with leading academic and research institutions, including McLean Hospital Corporation, the University of Maryland Baltimore, the University of Miami, the University of Pittsburgh, and the Icahn School of Medicine at Mount Sinai. These partnerships reflect a preference for established research entities with deep expertise in addiction science, neuroscience, and translational medicine. Her contracting patterns emphasize long-term, mission-aligned collaborations rather than transactional vendor relationships, often supporting multi-year research initiatives requiring specialized technical infrastructure and compliance with federal research standards. Her procurement activity is overwhelmingly non-set-aside, with 98.5% of awards issued under full and open competition, reflecting the specialized nature of the scientific capabilities required. Only 1.5% of awards are designated as total small business set-asides, indicating a focus on technical merit and domain expertise over socioeconomic preferences, though small business participation is not excluded where capabilities align. Landi’s primary NAICS focus areas include analytical laboratory instrument manufacturing (334516), testing laboratories and services (541380), and electronic equipment repair and maintenance (811210), underscoring her expertise in procuring high-precision research tools, validated testing protocols, and instrumentation support services. She frequently acquires custom-built or modified laboratory systems, biospecimen analysis platforms, and data acquisition technologies essential to modern addiction research.